Member Info for EmeraldCarrots

Orders so far THIS YEAR. We know the Scotland rollout is ongoing. We know Saudi Arabia are testing the MT-RNR1. We know Ireland has simply bought a few of these machines for one hospital based on the testing done to date so they are happy........

https://www.lse.co.uk/rns/GDR/holdings-in-company-0v1mtvtaqjpmgy0.html

Excellent.

Flyboo. You have a lot to learn.

Collaborating with Cellbxheath on? Test a sample of tumor tissue and do same for any circulating tumor cells found (CTC's) in the blood sample. Then compare the results. The question being how do the results compare and does doing both tests give more information? To me, if you are testing CTC's, the very cells that may spread the cancer, cells that have originated from the original tumor how on Earth can the information not be of use?

https://myriad.com/genetic-tests/precise-tumor/

Https://www.lse.co.uk/rns/GDR/holdings-in-company-6781ll52vkf9jhp.html

Interesting.

https://clinicaltrials.gov/study/NCT04520672?term=circulating%20tumor%20cell%20clusters&rank=2#study-overview

AI Overview

Yes, emerging research indicates that aspirin acts as a "cluster buster"

by inhibiting platelets and enabling the immune system to break up clusters of circulating cancer cells, thereby preventing metastasis.

Studies from the University of Cambridge, published in Nature, suggest that cancer cells often hide from the immune system by coating themselves in platelets, which helps them survive in the bloodstream and spread (metastasis). Aspirin interferes with this process in the following ways:

Immune System Boost: Aspirin inhibits platelets from producing a clotting factor called thromboxane A2 (TXA2). By reducing TXA2, immune T-cells are released from suppression, allowing them to destroy circulating cancer cells.

Preventing Metastasis: In animal models (mice), aspirin was shown to significantly reduce the spread of tumors.

Add-Aspirin Trial: Ongoing human clinical trials (the Add-Aspirin trial) are investigating whether daily aspirin can prevent the recurrence of cancer in patients.

Important Safety Warning: While showing potential in reducing cancer risk, particularly in colorectal, stomach, and ovarian cancers, regular aspirin use carries a risk of serious side effects, such as bleeding and stomach ulcers. It is critical to discuss taking regular aspirin with a healthcare professional before beginning.

How can one find out what "cluster buster" drugs are being trialed? Surely there are many trials going on testing cluster buster drugs??? Do the Pharma Plc's not bother any more? Or are the trials secret for some reason? The fact is that it is known people who were taking, of all things asprin for some other reason when suffering from cancer actually lived longer than those who did not. Apprently asprin helps stop the cells from sticking together to form the clusters. WHAT IS THE INDUSTRY DOING FFS to investigate this!

All IMHO.

A.I.

"Phase 3 "SUPRAME" Trial: Currently enrolling for cutaneous melanoma, with an interim analysis expected in Q1 2026 and a planned BLA submission in Q1 2027."

Update due in Q1 2026 then..........

"Using both CellSearch and Parsortix provides a comprehensive approach to Circulating Tumor Cell (CTC) analysis by combining epitope-dependent and label-independent methods. While CellSearch (FDA-cleared) excels at enumerating epithelial-marker-positive (EpCAM+) cells, Parsortix uses microfluidic size/deformability to capture diverse, including mesenchymal and EMT (epithelial-to-mesenchymal transition) cells, offering a more complete picture of tumor heterogeneity.".

Study using both:-

https://clinicaltrials.gov/study/NCT05988970?term=parsortix&rank=6&tab=study#collaborators-and-investigators

The Genedrive MT-RNR1 for every neonatal ward in the Country? The way things are going the hospitals Scotland will be fully kitted out first following their order. Then the other hospitals in Ireland I suspect and would you believe it Saudi Arabia may have the machines before all of England. It's sickening that NHS England helped Genedrive develop the machine in the first place. Its totally outrageous if you ask me and shows what chaos NICE is.

All IMHO.

Doing drug trials to test "cluster buster" drugs as clusters are suspected of being then main driver of cancer spread. But is the industry once again waiting for "someone else" to do the necessary trials? The more I learn about the cancer research industry the more annoyed I get. The biggest companies want "someone else" to fund trials, then they hope to buy that Company or do a deal. They make my blood boil. Governments should make the biggest Plc's invest say 15% or their profits in drug trials by law.

All IMHO.

If you ask me. This slide offers a 77% cell retention rate for CTC's. Market alternatives...... about 30%. So about a 47% gain. You would have thought s sales persons dream statistic to drive sales. I'm not surprised most of the old sales ream are gone!

from A.I.

Performance and Validation Data

"77% Retention Rate: Internal and collaborative studies have validated that the CellKeep slide achieves a 77% retention rate for CTCs. This is a significant improvement over traditional "market alternative" slides, which often yield only a 30% retention rate due to cell loss during laboratory processing.".

Team.

https://cellbxhealth.com/about-us/our-team/

Brett Swansiger who was the Chief Commercial Officer seems to have gone.

If so he was there just over 2 years and was obviously brought in to drive sales........

I think many shareholders were disappointed with the Companies sales performance, to say the least.

Illumina have a major interest, or say Astrazeneca! Thermofisher maybe. Lots of Companies might want a stake in fact if you ask me.

Means they were either done earlier today or a previous day.

Sp still up 6.98%.

Can be found by a general search for say "Cellbxhealth" on say google, the you can click on the link to see the post here. I doubt if all who post here knew that. In fact I'm certain many just think their posts are only seen by other posters on here. Very wrong. So if you want to spread information about a Company you can do so from here.

https://www.lse.co.uk/share-chat.html

Https://cellbxhealth.com/laboratory-services/ngs/

This CTC analysis finds about TWICE the number of cancer biomarkers as CtDna analysis alone, currently available for lung cancer.

The next news may wel be the next type of cancer it is available for.........

=====================

The industry is so SLOW in actioning progress with cancer research I find it totally depressing!

====================

"Dual analysis" for lung cancer, has been available from Cellbxheath from their services side since about last October!!!!!!

- You want to find cancer biomarkers so a lung cancer might be targeted by a modern drug............ WHERE DO YOU GO?????????

The industry is SO SLOW.

+6.98%.

Https://cellbxhealth.com/laboratory-services/ngs/

This CTC analysis finds about TWICE the number of cancer biomarkers as CtDna analysis alone, currently available for lung cancer.

The next news may wel be the next type of cancer it is available for.........

=====================

The industry is so SLOW in actioning progress with cancer research I find it totally depressing!